Blog

MBMA data curation: How AI and expert meta-analysts get it right, fast

In MBMA, the data layer is the real bottleneck. See how AI and expert meta-analysts…

Matt Zierhut, PhD MBAAugust 14, 2026

White Paper

Managing drug-drug interaction (DDI) risk for patients in clinical trials

Discover how DIDB® helps clinical teams assess drug-drug interaction risk, develop prohibited medication lists, &…

Katie Owens, PhDAugust 12, 2026

Conference

EANM 2026

–

Danielle PillsburyJuly 20, 2026

Webinar

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Hunter Stephens, PhDJuly 17, 2026

Publication

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…

CertaraJuly 16, 2026

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Matt Zierhut, PhD MBAJuly 9, 2026

Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Alekhya Lavu, PhD, PharmDJune 26, 2026

Poster

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices

Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…

CertaraJune 22, 2026

Blog

QSP modeling for Parkinson’s disease: Solving the synthetic control challenge in clinical trials

QSP modeling for Parkinson’s disease tackles optimized standard-of-care, placebo response, and missing biomarkers. See how…

CertaraJune 11, 2026

Publication

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…

Dorottya Gui-BodnarMay 28, 2026

Clinical Trials

MBMA data curation: How AI and expert meta-analysts get it right, fast

Managing drug-drug interaction (DDI) risk for patients in clinical trials

EANM 2026

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Enhancing clinical trials with real-world evidence in pregnancy research

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices

QSP modeling for Parkinson’s disease: Solving the synthetic control challenge in clinical trials

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

Newsletter sign up

Quick links

Solutions

Contact